Here's our longer-term price objective.
The charts of the life sciences company do not indicate that it is a good time to buy its stock despite how much it already has declined.
The technical signals indicate the odds of further weakness in the health care company's shares are low.
Let prices stabilize a bit on this speculative name, and then aggressive traders could probe opportunities for going long at this area.
The charts and indicators of ZBRA are touch and go right now.
The maker of specialty glass sees its shares take a hit, but Mudrick Capital jumps higher as the day for it taking Topps public nears.
Time to go long?
Here's our updated analysis and trading strategy.
Here's our first price objective.
Traders could go long at current levels risking below $240 for now.